What is the recommended dose of Doxofylline (Doxofylline) for a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxofylline Dosing in Children

For children over 6 years of age with asthma, the recommended dose of doxofylline is 6 mg/kg per dose twice daily (BID), which translates to approximately 12-18 mg/kg/day in divided doses. 1, 2

Age-Specific Recommendations

  • Children ≥6 years: 6 mg/kg/dose twice daily is the established pediatric dosing regimen 1
  • Children <6 years: Doxofylline is not recommended due to lack of safety and efficacy data in this age group 1

Clinical Context and Evidence

The dosing recommendation comes from retrospective pediatric data and recent clinical trials demonstrating efficacy in children with asthma:

  • A 2024 Mexican study used 18 mg/kg/day (divided doses) in children aged 6-16 years as a steroid-sparing agent, showing maintained lung function and improved asthma control 2
  • The 6 mg/kg/dose BID regimen produces stable serum concentrations without requiring routine plasma monitoring in healthy children 1

Monitoring Requirements

Plasma monitoring is only required in specific circumstances:

  • Children with hepatic insufficiency 1
  • Patients with documented intolerance to xanthine drugs 1
  • Unlike theophylline, routine therapeutic drug monitoring is not necessary due to doxofylline's stable pharmacokinetic profile 1

Safety Profile Advantages

Doxofylline demonstrates significantly fewer adverse effects compared to theophylline:

  • Only 5% of pediatric patients reported moderate side effects in retrospective data 1
  • Animal and human studies show reduced CNS stimulation, minimal effects on gastric acid secretion, and less cardiovascular toxicity compared to aminophylline 3
  • The drug has approximately 10-15 times lower adenosine receptor antagonism than theophylline, accounting for its improved tolerability 3

Clinical Application

Doxofylline may be used as add-on therapy in Step 3 and Step 4 asthma management in children over 6 years, extrapolating from adult data and limited pediatric studies 1, 2. It can serve as an alternative to theophylline when oral bronchodilator therapy is needed, particularly in resource-limited settings 1.

References

Research

Doxofylline: The next generation methylxanthine.

Indian journal of pediatrics, 2008

Research

Doxofylline as a steroid-sparing treatment in Mexican children with asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.